A return trip to the WNBA Finals is within reach for the New York Liberty when they hit the road Friday to face the Las Vegas Aces, who are trying to stave off the end to their two-year championship ...

The Tampa Bay Buccaneers ruled out five players for their NFC South game on Thursday night against the host Atlanta Falcons. All-Pro safety Antoine Winfield Jr. (foot) as well as right tackle Luke ...

The Milwaukee Brewers will turn to midseason acquisition Frankie Montas to stave off yet another postseason meltdown when they face the New York Mets on Wednesday in the second game of a National ...

Quarterback Deuce Knight, previously committed to Notre Dame, announced Wednesday that he instead will enroll at Auburn. Knight, from George County High School in Lucedale, Miss., is rated the ...

Titans quarterback Will Levis sustained an apparent right shoulder injury Monday night during the first quarter of Tennessee’s contest against the Miami Dolphins and was listed as questionable to ...

September witnessed a robust recovery in global equity fund inflows, signaling renewed investor confidence in global markets, according to HSBC. This resurgence in fund inflows highlights a shift in ...

Hall of Famer Dikembe Mutombo died Monday from brain cancer, the NBA announced. He was 58. Known for both his shot-blocking and finger-wagging in addition to a pronounced gravelly voice, Mutombo ...

Baker Mayfield’s sizzling performance carried the Tampa Bay Buccaneers to a 33-16 victory against the Philadelphia Eagles on ...

Jasmine Suwannapura of Thailand overcame a historic round from Lucy Li, sinking an eagle putt on the second playoff hole to emerge with a victory Sunday at the Walmart NW Arkansas Championship in ...

Tony Medley is an attorney, columnist, and MPAA-accredited film critic. His reviews are published in The Larchmont Chronicle, Telicom Magazines, The Tolucan Times, CWEB.com, robinhoodnews.com, ...

The season finale between the Houston Astros and the Cleveland Guardians was wiped out Sunday due to ongoing rain in the ...

Indaptus Therapeutics, Inc. (NASDAQ:INDP) is in a critical phase with its leading candidate, Decoy20, undergoing Phase I clinical trials, marking a significant step towards commercial viability. The ...